abstract |
The present invention relates to a synthetic polysulfated oligosaccharide having 1 to 4 monosaccharides, its salts, or its complexes, at a concentration greater than or equal to 70 mg / ml, for its use to activate angiogenesis, in particular to activate the angiogenesis during wound healing. |